Cardiology

Trial of bivalirudin during angioplasty reports mixed results

Patients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two co-primary endpoints—a composite of rate of death, heart ...

Cardiology

Diabetes drug shown not to increase heart failure risk

People with the most common form of diabetes can take the new drug Alogliptin without concern for an increased risk of heart failure or cardiovascular disease, according to research by a UConn cardiologist just published ...

Genetics

Researchers find genetic cues for a big heart

Bigger isn't always better, even when it comes to the body's most vital organs. An enlarged or thickened cardiac muscle can actually force the heart to work harder to pump blood throughout the body, weakening the organ until ...

Obstetrics & gynaecology

Women diagnosed with PCOS twice as likely to be hospitalized

Women diagnosed with polycystic ovary syndrome - the most common hormone disorder in women of reproductive age - face a heightened risk of developing heart disease, diabetes, mental health conditions, reproductive disorders ...

page 33 from 40